-
1
-
-
63249118690
-
Screening and prostate cancer mortality in a European Randomized Study
-
F.H. Schröder, J. Hugosson, and M. Roobol Screening and prostate cancer mortality in a European Randomized Study New Engl J Med 360 2009 1320 1328
-
(2009)
New Engl J Med
, vol.360
, pp. 1320-1328
-
-
Schröder, F.H.1
Hugosson, J.2
Roobol, M.3
-
2
-
-
78049457613
-
On the use of PSA for screening of prostate cancer in ERSPC
-
C. Bangma, R.H. van Schaik, and G. Blijenberg On the use of PSA for screening of prostate cancer in ERSPC Eur J Cancer 46 2010 3109 3119
-
(2010)
Eur J Cancer
, vol.46
, pp. 3109-3119
-
-
Bangma, C.1
Van Schaik, R.H.2
Blijenberg, G.3
-
3
-
-
78049470983
-
Prostate cancer incidence and mortality trends in 37 European countries
-
F. Bray, J. Lortet-Tieulent, J. Ferlay, and A. Auvinen Prostate cancer incidence and mortality trends in 37 European countries Eur J Cancer 46 2010 3040 3052
-
(2010)
Eur J Cancer
, vol.46
, pp. 3040-3052
-
-
Bray, F.1
Lortet-Tieulent, J.2
Ferlay, J.3
Auvinen, A.4
-
4
-
-
78049479810
-
PSA levels and cancer detection rates in the European Randomised Study of Screening for Prostate Cancer
-
S.J. Otto, S.M. Moss, and L. Määttänen PSA levels and cancer detection rates in the European Randomised Study of Screening for Prostate Cancer Eur J Cancer 46 2010 3053 3060
-
(2010)
Eur J Cancer
, vol.46
, pp. 3053-3060
-
-
Otto, S.J.1
Moss, S.M.2
Määttänen, L.3
-
5
-
-
78049465045
-
Blinded and uniform causes of death verification in cancer screening
-
S.J. Otto, P.J. van Leeuwen, and J.W. Hoekstra Blinded and uniform causes of death verification in cancer screening Eur J Cancer 46 2010 3061 3067
-
(2010)
Eur J Cancer
, vol.46
, pp. 3061-3067
-
-
Otto, S.J.1
Van Leeuwen, P.J.2
Hoekstra, J.W.3
-
6
-
-
78049479293
-
Lead-time in the European Randomised Study of Screening for Prostate Cancer
-
P. Finne, M. Fallah, and M. Hakama Lead-time in the European Randomised Study of Screening for Prostate Cancer Eur J Cancer 46 2010 3102 3108
-
(2010)
Eur J Cancer
, vol.46
, pp. 3102-3108
-
-
Finne, P.1
Fallah, M.2
Hakama, M.3
-
7
-
-
78049484758
-
Interval cancers in the Antwerp ERSPC study
-
V. Nelen, G. Thys, and A. Hermans Interval cancers in the Antwerp ERSPC study Eur J Cancer 46 2010 3090 3094
-
(2010)
Eur J Cancer
, vol.46
, pp. 3090-3094
-
-
Nelen, V.1
Thys, G.2
Hermans, A.3
-
8
-
-
78049472438
-
Detection rates of cancer, high-grade PIN and atypical lesions suspicious for cancer in the European Randomised Study of Screening for Prostate Cancer
-
M. Laurila, T. van der Kwast, and L. Bubendorf Detection rates of cancer, high-grade PIN and atypical lesions suspicious for cancer in the European Randomised Study of Screening for Prostate Cancer Eur J Cancer 46 2010 3068 3072
-
(2010)
Eur J Cancer
, vol.46
, pp. 3068-3072
-
-
Laurila, M.1
Van Der Kwast, T.2
Bubendorf, L.3
-
9
-
-
78049462343
-
Change of tumor characteristics and treatment over time in both arms of the European Randomized Study of Screening for Prostate Cancer
-
S. Boevee, L.D.F. Venderbos, and M.J. Roobol Change of tumor characteristics and treatment over time in both arms of the European Randomized Study of Screening for Prostate Cancer Eur J Cancer 46 2010 3082 3089
-
(2010)
Eur J Cancer
, vol.46
, pp. 3082-3089
-
-
Boevee, S.1
Venderbos, L.D.F.2
Roobol, M.J.3
-
10
-
-
78049476773
-
Deciding on PSA screening - Quality of current consumer information
-
I.J. Korfage, R.C.N. van den Bergh, and M.-L. Essink-Bot Deciding on PSA screening - quality of current consumer information Eur J Cancer 46 2010 3073 3081
-
(2010)
Eur J Cancer
, vol.46
, pp. 3073-3081
-
-
Korfage, I.J.1
Van Den Bergh, R.C.N.2
Essink-Bot, M.-L.3
-
11
-
-
78049462739
-
Latest results from the UK trials evaluating prostate cancer screening and treatment: The CAP and ProtecT studies
-
D. Lane, F.C. Hamdy, and R.M. Martin Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies Eur J Cancer 46 2010 3095 3101
-
(2010)
Eur J Cancer
, vol.46
, pp. 3095-3101
-
-
Lane, D.1
Hamdy, F.C.2
Martin, R.M.3
|